DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION DANAZOL IN API AND COMBINED DOSAGE FORM

In: World Journal of Pharmaceutical and life sciences · 2005 · vol. 2018 · W2982012250
OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study developed and validated an RP-HPLC method for the simultaneous estimation of Danazol in both its Active Pharmaceutical Ingredient (API) and a combined dosage form.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-10T10:08:28.574868+00:00
License: CC0 · commercial use OK